Signaling through OX40 (CD134) breaks peripheral T-cell tolerance

Author:  ["Pratima Bansal-Pakala","Amha Gebre-Hiwot Jember","Michael Croft"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Peripheral T-cell tolerance is a mechanism to limit autoimmunity, but represents a major obstacle in diseases such as cancer. Tolerance is due to limited accumulation of antigen-specific T cells accompanied by functional hypo-responsiveness, and is induced by antigen encounter in a non-inflammatory environment. In contrast to advances in preventing induction of T-cell tolerance, there has been little progress in defining targets to reverse established tolerance. Here we show that signals from a single dose of an agonistic antibody against OX40 (CD134, a member of the tumor necrosis-factor family of receptors) can break an existing state of tolerance in the CD4+ T-cell compartment. OX40 signals promote T-cell expansion after the hypo-responsive phenotype is induced and restore normal functionality. These data highlight the potent costimulatory capacity of OX40, and indicate OX40 as a target for therapeutic intervention in a variety of related diseases.

Cite this article

Bansal-Pakala, P., Gebre-Hiwot Jember, A. & Croft, M. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat Med 7, 907–912 (2001). https://doi.org/10.1038/90942

View full text

>> Full Text:   Signaling through OX40 (CD134) breaks peripheral T-cell tolerance

Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1

Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of